TG Therapeutics (TGTX)

TG Therapeutics (TGTX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• TGTX last traded at $60.51, -1.10% on the day.
• TG Therapeutics: market cap $9.36B, P/E 19.9, revenue $799.54M over the last four quarters, next earnings 2026-11-02.
• Over the past year TGTX returned 77.87%; year to date 102.99%.

Updated 2026-11-02 17:50 UTC